Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer
In November 2021, Cancer Research UK Chief Clinician, Professor Charles Swanton, visited our longstanding corporate partner ScottishPower at their headquarters…
Finding lung cancer early makes it much easier to treat. Dr Samantha Quaife, an expert in lung screening, explains how it can save lives and fight inequality.
From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back.
When diagnosed with cancer, deciding how and when to tell people can leave a patient feeling anxious and alone. For…
The “potentially life-saving” immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales.
Today, we’ve announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx.
Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She’s using all she’s learned to create better treatments for solid tumours in children.
Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future.